The Cure Parkinson's Trust & Parkinson’s Community Mourn the Loss of Their Champion Tom Isaacs

“So how has the task of finding better treatments for Parkinson’s made me more passionate, more determined and more fulfilled in my life than I ever thought possible? The answer to this question is simple. It’s the people. My involvement with Parkinson’s has been motivated solely by the brilliance of scientists, the generosity of philanthropists, the selflessness of those friends or family with Parkinson’s and, above all else, the incredible ability of the human spirit to overcome extreme adversity of health. It is the knowledge that these people are out there; that there is the ability, the resource and the will to make a difference and improve the lives of those of us who have Parkinson’s, which has given both me and all my colleagues at The Cure Parkinson’s Trust our sense of purpose, enthusiasm and commitment. It is humbling to know that so many fantastic people are out there and that their sole mission is to rid the world of Parkinson’s" - Tom Isaacs - President & Co-founder of The Cure Parkinson's Trust (CPT)

When Tom Isaacs set up The Cure Parkinson’s Trust 12 years ago, he was determined to conquer the disease for everyone living with Parkinson’s and he bravely and single-mindedly fought to achieve this aim. Under his guidance, The Cure Parkinson’s Trust has become a key player in the world of research, setting up and funding the International Linked Clinical Trials initiative and taking a leading role in research conferences throughout the world. Tom’s total comprehension of the biochemistry behind his condition enabled him to take part in scientific discussions at the highest level. He earned the respect and support of such leading Parkinson’s researchers as Professors Andrew Lees, Anders Bjorklund, Patrik Brundin, Roger Barker, Tom Foltynie and Steven Gill.

Tom Isaacs qualified as a chartered surveyor and was working as a director of a London property company when he was diagnosed with Parkinson’s (PD) in 1995 - he was just 26. At that time, scientists and doctors accepted without question that Parkinson’s was an incurable condition and drugs were prescribed to alleviate symptoms of the disease. Progress in research was slow and pre-clinical work was focused on cause and needed to be more coordinated. Tom simply could not accept this and began asking “why?” and investigating the underlying state of affairs in the Parkinson’s community and research arena. He determined that one day he would be able to insert the words “used to” when he said, “I have Parkinson’s”.

Sadly, that was not to be; but his incredible work in the intervening years between diagnosis and his death on 31st May 2017 at the age of 49 has brought this vision tantalisingly close for the many others with the condition.

From the outset, the focus for Tom had to be about a cure.

“The word cure was never used… you knew it was forbidden. Cure was seen as a false hope. And actually if you don't have hope in Parkinson's disease, you don't have anything. Back then we needed something focused on the research not just on the care... and it needed to be more edgy, more feisty…”

Tom’s single minded approach to his condition gave him the tenacity to set himself on a clear path.

“My walk ‘Coastin’’ provided the platform for everything that was to follow and led to my meeting seven extraordinary people without whom The Cure Parkinson’s Trust simply would never have come into being. The “magnificent seven” were my wife, Lyndsey; Professor Andrew Lees, who at the time was my neurologist, the other three original “movers and shakers” Sir David Jones, Sir Richard Nichols and Air Vice Marshal Michael Dicken, fellow people with Parkinson’s; Professor Steven Gill from Frenchay Hospital, Bristol; and a remarkable and industrious force of nature in the form of Helen Matthews. Two years after Coastin’, we set up The Cure Parkinson’s Trust, determined to help the push towards a cure in any way we could.”

Tom’s incredible sense of humanity and amazing talent for bringing people together when most needed was truly an irresistible force.

He used his charm and single-mindedness to forge new links between scientists and patients while remaining unafraid to criticise science when he felt it was too divorced from the everyday reality of living with Parkinson’s."This is me. This is us,” he said. “Find the cure."

In 2006, CPT organised a fund-raising game against the Royal Household Cricket Club. Fortuitously, one of the players on the Royal Household team turned out to be a distinguished paediatric cardiologist, a Council Member of the Royal Society of Medicine, and an expert in evidence-based medicine. His name - Dr Richard Wyse.

“He had the feisty, irreverent manner that matched the new organisation… which is exactly what we needed… so we let him loose to see what damage he could do, and he did some real damage. He dared to challenge a few scientists, but gradually people realised he knew what he was talking about and he soon became a bit of an expert on everything.”

Together, Tom and Richard Wyse began forging ahead with international collaborations. The first was with Swedish neuroscientist Patrik Brundin (of the Van Andel Institute in Grand Rapids, Michigan) to develop a programme to investigate existing drugs with a view to “repurposing” them for PD and their likely impact and ability to slow, stop or reverse the condition – theLinked Clinical Trials initiative (LCT). The LCT is now in its fifth year. Tom’s name appears on the first report by the LCT committee, which is published in the Journal of Parkinson's Disease. Tom is also a co-author on a paper testing the diabetes drug Exenatide for PD, which is published in the Journal of Clinical Investigation and has co-authored many other papers in Parkinson's studies.

Another collaboration with the University of Tuebingen emerged from a presentation Tom gave at the World Parkinson Congress 2010 in Glasgow where he highlighted the need to find better ways to monitor the progression of PD. Tom led the charity’s involvement in an EU funded project to capture information about how PD progresses in different patients. Understanding what is happening to a person with Parkinson’s affects how they are treated (leading to personalised treatment plans) but also if accurate measurement is used in clinical trials rather than a clinical snapshot, Tom recognised that this would allow the chance to see if a treatment is actually changing the course of the disease.

Tom’s ability to communicate with people from every background was exceptional. Speaking in theVatican about stem cellsled to an audience with the Supreme Pontiff, Pope Francis (and inspired Tom's delightful and humorous own song - 'Grow every stem cell..!'). Tom worked closely with the Michael J. Fox Foundation and was adept at recruiting celebrities whose lives or families had been affected by the disease. He was impressive on the radio, walking with Clare Balding in 2003 and then again in a follow-up in 2015 for her ‘Ramblings’ programme. He was interviewed on all Parkinson's related stories on a number of occasions with Jeremy Vine on his BBC Radio 2 programme. Tom presented a Radio 4 documentary - 'Young Man Old Body' and the follow-up ‘Chasing a Cure’ which were nominated for Sony Awards. He also appeared on BBC Radio 4 'Mid-Week' to launch his book “Shake Well Before Use” (4,250 copies sold); was named Charity Personality of the year in 2004 and was an Olympic torchbearer in 2012! A brilliant and inspirational speaker, his self-deprecating humour put his audience at ease despite the flailing arms and loss of balance of his Parkinson’s. “I have been asked to be short but moving,” he would declare. “At 5’7 I am certainly short and… I am always moving.” His immense personal charm endeared him to everyone he met, winning new supporters for the charity. Above all, he inspired people with Parkinson’s, giving them hope and a belief that their voice was being heard.

“From the Trust’s inception we believed that it was critical that we made sure every research project we supported was evaluated by, and relevant to, people living with Parkinson’s. As we were founded and led by people with Parkinson’s, we remain true to these guiding principles. The involvement of people with Parkinson’s in every aspect of our work has led to the growing importance and influence of our ambition.There is one thing that motivates me more than anything; it is the idea of finding a deliverable treatment that can reverse the course of this cruel illness. I believe that this is attainable. For me, one of the biggest challenges – and yet also the biggest opportunity – is galvanising people who live with Parkinson’s from day to day to engage with their condition. If everyone with Parkinson’s were to communicate their experiences of living with Parkinson’s; if everyone participated in clinical trials; if everyone took the time to become more knowledgeable and was more committed to partnering the scientific community in the search for new treatments, then there is no doubt in my mind that progress can be accelerated in Parkinson’s research.”

Tom’s incredible achievements within the Parkinson's community and with the Trust he co-founded did impact on his health. After 23 years with Parkinson’s, each day was a huge physical battle for Tom. His Parkinson’s manifested itself with erratic fluctuating ‘on’ and ‘off’ periods from the medication, often with painful dystonia or cramping. He experienced unyielding dyskinesias and was seldom able to remain still, his body continued to move fitfully and uncontrollably and problems with balance meant he frequently fell – there was no physical or mental quiet for him. But part of Tom's legacy is that he never shied away from showing the reality of Parkinson’s, and he continued to stress the urgent need for a cure.

“Few patients enjoy hearing the word incurable when initially diagnosed. There is no more dispiriting word in the language than one which eliminates 'Hope' and without hope of a better future how can anyone expect to enjoy a decent quality of life in the present. Try asking a newly diagnosed patient whether they would prefer to be treated or cured.”

Of course it takes more than hope and, through The Cure Parkinson’s Trust, Tom made sure 'there's money where the mouth is' - money for research and to champion those drugs or treatments that offer the best chance of a cure.

By putting himself out there, even as the going got tough, he never let anyone forget why a cure is needed, but it was never in a way other than to inspire – and he was certainly inspirational!

It remains the mission of this incredible charity to continue with Tom’s vision; to fulfil his dream and to inspire others to join the team and fight on. A cure is out there: we are more determined than ever to find it.Please support Tom's Memorial Appeal now.

Lyndsey, Tom’s beloved wife, fully embraced Tom’s vision and was an advocate for Parkinson’s in her own right. Her phenomenal support for Tom enabled him to travel extensively, making impactful speeches at conferences about the urgent need for a cure, the power of advocacy in research, the impact of living with Parkinson’s and the importance of Hope which he described as “the best medicine of all”. Tom and Lyndsey not only shared a vision but also a wonderful sense of humour, friendship and fun, and a huge sense of adventure.

"Tom's passion, determination and hard work on behalf of everyone living with Parkinson's were the hallmark of his life and will be his continuing legacy in our community. Our Foundation was fortunate to know him and to partner with The Cure Parkinson's Trust toward our shared mission to speed a cure." - Michael J. Fox - Actor and Activist, of The Michael J. Fox Foundation

‘In the list of inspirations I've had the privilege of meeting, you two are right up there with Nelson Mandela; - the hole Tom leaves will be colossal’ - Caroline Chartres, wife of The Bishop of London Richard Chartres.

"…he will always be our favourite walking companions on 'Ramblings'. He was so bright, so full of ideas and energy, so wickedly funny and deliberately provocative. I admired and liked him enormously." - Clare Balding - TV & Radio Presenter

"Tom was a 'man of parts' who combined a rare grouping of human qualities, not least amongst which, was the gracious and selfless way in which he bore his illness. He had a penetrating eye, attention and manner which combined with his compassion and determination, made his company irresistible. He was not a man one could ignore. Tom mobilised these aspects of his character to energise efforts to seek a cure to the affliction from which he and countless others suffer.’ – Rupert Phelps – Chairman - The Gulls' Eggs and Grouse & Grape Committees

"Whenever I saw Tom he always provided the encouragement I needed to keep me going. Like recharging a battery. He is irreplaceable but we must learn to generate enough energy without him." - Richard Windle - Parkinson's Patient Advocate

"Tom was always so inspiring and hope went through a room the times I heard him speak. Flipping condition....awful. It's good to hear that this increases your determination. Keep going and the break through will come." - Tim Vine - Television and Radio Comedian

"Despite his debilitating symptoms Tom led from the front, he proudly carried a beacon of advocacy and hope for many years; diagnosed in his late 20's, Tom was handed 'a lamp to light the way' for others who followed, and will continue to, in his footsteps, (at the start of their own unique journey with PD). He will be sorely missed." - David Sangster - Parkinson's Advocate & Awareness Campaigner

"He has laid down the gauntlet, and we must deliver for him… I'm in tears in my office." - Dr Tilo Kunath - MRC Centre for Regenerative Medicine

"Tom meant an enormous amount to many people in the Parkinson community. He was a key figure in the World Parkinson Congress – he was a powerful spokesman for people everywhere with Parkinson’s, but also a keen advocate for respectful partnership between PwP and for the importance for PwP to participate in clinical trials. Despite the impact that PD had on his personal health, Tom unfailingly displayed enormous dignity, tempered by humility, an extraordinary sense of humour, a remarkable capacity to carry a tune and to make other people see the positive in life." - Jon Stoessl - Director, Pacific Parkinson's Research Centre, Canada

Special thanks to: Jon Palfreman who interviewed Tom at the Third World Parkinson Congress in Montreal in October 2013, to Jemima Harrison of Passionate Productions for her insightful words and to theANCR 2015 (online article).

Latest

For some considerable time CPT has been interested in nerve growth factors or 'neurotrophic' factors for Parkinson's. GDNF, CDNF and C-CDNF are three interesting candidates and our research work within this field continues with drive and urgency.

Dr. Johnny Acheson is an Emergency Medical Consultant who is also living with Parkinson’s. Johnny has created sketches to fundraise and to educate about Parkinson’s and depict the humorous side of working in emergency medicine!

Over 50 cyclists, including Mike Tindall and Iain Balshaw, will set off independently on 28 June to tackle what would have been the toughest day on the 'Raid Alpine' ride - but instead, they'll be doing this around their local area!

Related

For some considerable time CPT has been interested in nerve growth factors or 'neurotrophic' factors for Parkinson's. GDNF, CDNF and C-CDNF are three interesting candidates and our research work within this field continues with drive and urgency.

Dr. Johnny Acheson is an Emergency Medical Consultant who is also living with Parkinson’s. Johnny has created sketches to fundraise and to educate about Parkinson’s and depict the humorous side of working in emergency medicine!

Over 50 cyclists, including Mike Tindall and Iain Balshaw, will set off independently on 28 June to tackle what would have been the toughest day on the 'Raid Alpine' ride - but instead, they'll be doing this around their local area!

Dr Camille Carroll of Plymouth University, a member of our International Linked Clinical Trials (iLCT) committee, has led a group of researchers in exploring a platform for conducting Multi-Arm Multi-Stage clinical trials for Parkinson's.

From Sunday the 26 April, supporters of The Cure Parkinson’s Trust came together to join the nationwide 2.6 Challenge, taking part in unique activities based around the number 2.6 or 26. Here we share some of the imaginative challenges our supporters took on.

At present there is little or no research being undertaken on the impact of COVID-19 on the Parkinson's community. Now, Fox Insight has stepped up to the plate to facilitate this important emerging area of research.

Most read

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

At this current time, we are working remotely and are unable to fulfill orders made via our online shop. We kindly ask that you refrain from purchasing items until normal working practices are resumed. Thank you for your patience. Please stay safe and well. From all at CPT.